CLIA Mycoplasma IgM
The chemiluminescence assay is intended for the diagnosis of Mycolasma pneumoniae infection using IgM antibodies in human serum or plasma in the general population.
Runs on
KleeYa® Automated CLIA Analyser
See the analyser and everything it runs
Quote-based, no public pricing. Add to your quote and our specialists put together a proposal with the right documentation, typically within 24 hours.
This kit in detail
Description
Mycoplasma pneumoniae is a primary pathogenic agent of the human respiratory tract. It causes pneumonia accompanied by fever, nausea, ague, cough, and fatigue. The disease is prolonged but well curable with antibiotics. The pathogen is airborne, spread especially in dense gatherings of children, particularly during spring and autumn months.
Technical data
- Assay time: 30 min
- Assay stability: 30 days on board stability / In use stability until the expiration date at storage temperature 2-8 °C
- Sample matrix: Serum, Plasma
- Sample volume: 10 μL
- Measuring range: 2–160 U/ml
- Complementary products: Anchor® Tips, Stackable Cuvette, KleeYa Trigger Pack, KleeYa Wash buffer
- Note: The kits are CE-IVD certified and intended for professional use.
Specifications
- Catalog Number: CL-MyM100
- Size: 100 tests
- Regulatory status: CE IVD
- Clinical topic: Infectious Diseases
- Diagnostic panel: COVID-19 Respiratory Diseases
- Producer: TestLine Clinical Diagnostics s.r.o.
References
- 11728052,15018643,11548186,8399936,11979130,870608,6809846,2124271,12603292,8909826
- Reagent Cartridge with specific reagents for the assay
- magnetic particles
- calibrators
Datasheets and regulatory documentation
Everything your quality team needs for evaluation and procurement.
Safety information
Product brochure
Declaration of conformity
Add this kit to your quote
Tell us the platforms and throughput you’re planning for and our specialists will put together a clear proposal with the right documentation, no public pricing, just a considered answer.
